Skip to main content
· 6/23/2004

Xechem, Inc., and Xechem International, Inc. v. Bristol-Myers Squibb Company

Citations

  • 372 F.3d 899
  • 71 U.S.P.Q. 2d (BNA) 1220
  • 2004 U.S. App. LEXIS 12424
  • 2004 WL 1396243

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that a plaintiff pleads himself out of court when his complaint includes all the necessary ingredients of an impenetrable defense
  • finding that an action taken to extend the five-year exclusivity period for -marketing a pharmaceutical was sufficient to restart the statute of limitations
  • reversing dismissal of complaint and declining to affirm dismissal on the alternative ground that plaintiff had not shown injury even when it had not yet filed an ANDA
  • “Only when the plaintiff pleads itself out of court--that is, admits all the ingredients of an impenetrable defense--may a complaint that otherwise states a claim be dismissed under Rule 12(b)(6).”
  • “Complaints need not contain any information about defenses and may not be dismissed for that omission.”
  • failure to “plead around” a likely affirmative defense is typically not a proper basis for dismissal

Source: CourtListener parenthetical corpus (CC0).

Judges: Diane, Easterbrook, Kanne, Wood

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.